Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 51–100 of 1,994 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07259616	Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities	completed	—	46,079	Gynaecologisch Oncologisch Centrum ZuidOTHER	0	Sep 15, 2026	clinicaltrials
NCT00791635	Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer	active not recruiting	—	79	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026